{"product_id":"atlas-of-dermatopathology-9781119371540","title":"Atlas of Dermatopathology","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eDifferential diagnosis is at its most accurate and efficient when clinical presentation and histopathological features are considered in correlation with one another. With this being so, the expert team behind this atlas has integrated both perspectives to create an innovative and essential resource for all those involved with the diagnosis of tumors, cysts, and nevi. Almost 1,400 full-color images clearly illustrate common patterns and variants of tumorous lesions of the skin and are helpfully contextualized by concise, straightforward descriptions of key features and diagnostic clues.\u003c\/p\u003e \u003cp\u003eWhether they are aspiring or experienced practitioners, dermatologists and pathologistsof all levels will find this an insightful and practically applicable addition to their bookshelf. Its far-reaching and easy-to-navigate coverage of relevant diseases of the skin provides trainees with an excellent grounding in the area, while practicing specialists may benefit from its use as a tool for the\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003ePreface xv\u003c\/p\u003e \u003cp\u003eAcknowledgments xvii\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 EPIDERMIS 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eNevi 2\u003c\/p\u003e \u003cp\u003eEpidermal Nevus 2\u003c\/p\u003e \u003cp\u003eVariant: Inflammatory Linear Verrucous Epidermal Nevus (ILVEN) 3\u003c\/p\u003e \u003cp\u003eKeratoses 4\u003c\/p\u003e \u003cp\u003eSeborrheic Keratosis (SK) and Variants 4\u003c\/p\u003e \u003cp\u003eVariant: Acanthotic Seborrheic Keratosis 4\u003c\/p\u003e \u003cp\u003eVariant: Reticulated, Pigmented Seborrheic Keratosis 6\u003c\/p\u003e \u003cp\u003eVariant: Flat Seborrheic Keratosis 6\u003c\/p\u003e \u003cp\u003eVariant: Papillomatous Seborrheic Keratosis 7\u003c\/p\u003e \u003cp\u003eVariant: Activated (Irritated) Seborrheic Keratosis 7\u003c\/p\u003e \u003cp\u003eVariant: Dermatosis Papulosa Nigra 7\u003c\/p\u003e \u003cp\u003eVariant: Melanoacanthoma (Pigmented Seborrheic Keratosis) 8\u003c\/p\u003e \u003cp\u003eVariant: Clonal (Intraepidermal) Seborrheic Keratosis (Borst– Jadassohn) 9\u003c\/p\u003e \u003cp\u003eVariant: Seborrheic Keratosis with Monster Cells (Bowenoid) 10\u003c\/p\u003e \u003cp\u003eVariant: Hyperkeratotic Seborrheic Keratosis (Stucco Keratosis) 11\u003c\/p\u003e \u003cp\u003eConfluent and Reticulate Papillomatosis (Gougerot and Carteaud) 12\u003c\/p\u003e \u003cp\u003eReticulate Pigmented Anomaly of the Flexures (Dowling–Degos Disease) 13\u003c\/p\u003e \u003cp\u003eAcanthosis Nigricans 14\u003c\/p\u003e \u003cp\u003eSolar (Actinic) Keratosis 15\u003c\/p\u003e \u003cp\u003eVariant: Acantholytic Solar Keratosis 16\u003c\/p\u003e \u003cp\u003eVariant: Atrophic Solar Keratosis 16\u003c\/p\u003e \u003cp\u003eVariant: Lichen Planus‐Like Solar Keratosis 17\u003c\/p\u003e \u003cp\u003eVariant: Hypertrophic (Bowenoid) Solar Keratosis 18\u003c\/p\u003e \u003cp\u003eCornu Cutaneum 18\u003c\/p\u003e \u003cp\u003eAcanthomas, Non‐Viral 19\u003c\/p\u003e \u003cp\u003eSolar Lentigo 19\u003c\/p\u003e \u003cp\u003eCallus, Factitial Acanthoma 20\u003c\/p\u003e \u003cp\u003eKnuckle Pads (Chewing Pads) 21\u003c\/p\u003e \u003cp\u003ePale (Clear) Cell Acanthoma 22\u003c\/p\u003e \u003cp\u003eLarge Cell Acanthoma 23\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis: Epidermolytic Acanthoma 24\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis: Congenital Ichthyosiform Erythroderma 25\u003c\/p\u003e \u003cp\u003eAcantholytic Acanthoma 26\u003c\/p\u003e \u003cp\u003eWarty Dyskeratoma 27\u003c\/p\u003e \u003cp\u003ePorokeratoma (Porokeratosis Mibelli) 30\u003c\/p\u003e \u003cp\u003eAcanthomas, Viral 31\u003c\/p\u003e \u003cp\u003eVerruca Vulgaris 31\u003c\/p\u003e \u003cp\u003eVariant: Verruca Plana 33\u003c\/p\u003e \u003cp\u003eVariant: Condyloma Acuminatum 34\u003c\/p\u003e \u003cp\u003eBowenoid Papulosis 35\u003c\/p\u003e \u003cp\u003eAcrokeratosis Verruciformis (Hopf) 37\u003c\/p\u003e \u003cp\u003eMolluscum Contagiosum 38\u003c\/p\u003e \u003cp\u003e“Pseudocarcinomas” and Neoplasms with Intermediate Malignant Potential 40\u003c\/p\u003e \u003cp\u003eKeratoacanthoma (KA) 40\u003c\/p\u003e \u003cp\u003eEpithelioma Cuniculatum (Verrucous Carcinoma) (EC\/VC) 44\u003c\/p\u003e \u003cp\u003ePapillomatosis Cutis Carcinoides 45\u003c\/p\u003e \u003cp\u003eFlorid Papillomatosis of the Oral Cavity (Oral Verrucous Carcinoma) 46\u003c\/p\u003e \u003cp\u003eBuschke–Löwenstein Tumor (Giant Condyloma) 47\u003c\/p\u003e \u003cp\u003eMalignant Epidermal Neoplasms 48\u003c\/p\u003e \u003cp\u003eBowen’s Disease (Carcinoma in situ) 48\u003c\/p\u003e \u003cp\u003eVariant: Clear Cell Bowen’s Disease 50\u003c\/p\u003e \u003cp\u003eVariant: Cutaneous Horn (Cornu Cutaneum) on Bowen’s Disease 51\u003c\/p\u003e \u003cp\u003eVariant: Pigmented (Anogenital) and Clonal Bowen’s Disease 52\u003c\/p\u003e \u003cp\u003eVariant: Erythroplasia of Queyrat and Vulvar Intraepithelial Neoplasia 53\u003c\/p\u003e \u003cp\u003eBasal Cell Carcinoma (BCC) 54\u003c\/p\u003e \u003cp\u003eVariant: Nodular BCC 54\u003c\/p\u003e \u003cp\u003eVariant: Infundibulocystic BCC 56\u003c\/p\u003e \u003cp\u003eVariants of BCC With Ductal, Matrical or Sebaceous Differentiation 57\u003c\/p\u003e \u003cp\u003eVariant: Superficial BCC 60\u003c\/p\u003e \u003cp\u003eVariant: Pigmented BCC 61\u003c\/p\u003e \u003cp\u003eVariant: Adenoid‐Cystic BCC 62\u003c\/p\u003e \u003cp\u003eVariant: Sclerodermiform (Morpheaform) BCC 64\u003c\/p\u003e \u003cp\u003eClinical Variants: Ulcerating BCCs 66\u003c\/p\u003e \u003cp\u003eHistological Variants: Metatypic BCC with Squamoid Differentiation 67\u003c\/p\u003e \u003cp\u003eSyndromatic BCC (Basal Cell Nevus Syndrome, Gorlin–Goltz) 69\u003c\/p\u003e \u003cp\u003eFibroepithelioma of Pinkus 70\u003c\/p\u003e \u003cp\u003eSquamous Cell Carcinoma (SCC) 72\u003c\/p\u003e \u003cp\u003eVariant: Well‐Differentiated SCC 72\u003c\/p\u003e \u003cp\u003eVariant: Acantholytic SCC (Epithelioma Spinocellulare Segregans of Delacretaz) 74\u003c\/p\u003e \u003cp\u003eVariant: Myxoid SCC 76\u003c\/p\u003e \u003cp\u003eVariant: Follicular (Infundibular) SCC 77\u003c\/p\u003e \u003cp\u003eVariant: Spindle Cell (Fusicellular) SCC 78\u003c\/p\u003e \u003cp\u003eSquamous Cell Carcinomas in Special Sites 79\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 ADNEXAL 85\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eSweat Gland Differentiation 86\u003c\/p\u003e \u003cp\u003eNevi, Hyperplasias, and Benign Adnexal Neoplasms (BAN) 86\u003c\/p\u003e \u003cp\u003eEccrine Differentiation 86\u003c\/p\u003e \u003cp\u003eApocrine Differentiation 93\u003c\/p\u003e \u003cp\u003eMalignant Adnexal Neoplasms 105\u003c\/p\u003e \u003cp\u003eEccrine Differentiation 105\u003c\/p\u003e \u003cp\u003eApocrine Differentiation 109\u003c\/p\u003e \u003cp\u003eSebaceous Differentiation 110\u003c\/p\u003e \u003cp\u003eHyperplasias and Hamartomas 111\u003c\/p\u003e \u003cp\u003eEctopic (Heterotopic) Sebaceous Glands (Fordyce Glands) 111\u003c\/p\u003e \u003cp\u003e(Senile) Sebaceous Gland Hyperplasia 112\u003c\/p\u003e \u003cp\u003eNevus Sebaceous (Jadassohn) 113\u003c\/p\u003e \u003cp\u003eVariant: Pilo‐Sebaceous Hamartoma 114\u003c\/p\u003e \u003cp\u003eBenign Neoplasms 114\u003c\/p\u003e \u003cp\u003eSebaceous Adenoma 114\u003c\/p\u003e \u003cp\u003eMuir–Torre Syndrome 115\u003c\/p\u003e \u003cp\u003eSebaceous Epithelioma (Sebaceoma) 116\u003c\/p\u003e \u003cp\u003eMalignant Neoplasms 118\u003c\/p\u003e \u003cp\u003eSebaceous Carcinoma 118\u003c\/p\u003e \u003cp\u003eHair Follicle Differentiation 119\u003c\/p\u003e \u003cp\u003eNevi, Hyperplasia, and Hamartomas 119\u003c\/p\u003e \u003cp\u003eHair Follicle Nevus 119\u003c\/p\u003e \u003cp\u003eConical Infundibular Acanthoma (Giant Dilated Pore of Winer) 120\u003c\/p\u003e \u003cp\u003eBenign Neoplasms 121\u003c\/p\u003e \u003cp\u003ePilar Sheath Acanthoma 121\u003c\/p\u003e \u003cp\u003eTrichilemmoma (Tricholemmoma) 122\u003c\/p\u003e \u003cp\u003eTumor of the Follicular Infundibulum (Infundibuloma) 124\u003c\/p\u003e \u003cp\u003eTrichoepithelioma (Superficial Trichoblastoma) 125\u003c\/p\u003e \u003cp\u003eTrichoblastoma (Trichoblastic Fibroma; Immature Trichoepithelioma) 127\u003c\/p\u003e \u003cp\u003eTrichoepithelioma (Sclerosing Epithelial Hamartoma) 131\u003c\/p\u003e \u003cp\u003eTrichofolliculoma (Folliculosebaceous Cystic Hamartoma) 133\u003c\/p\u003e \u003cp\u003eTrichoadenoma (Nikolowski) 136\u003c\/p\u003e \u003cp\u003ePilomatricoma (Calcifying Epithelioma Malherbe) 137\u003c\/p\u003e \u003cp\u003eProliferating Trichilemmal (Pilar) Tumor (PTT) (Proliferating Trichilemmal Cyst) 138\u003c\/p\u003e \u003cp\u003eMalignant Neoplasms 140\u003c\/p\u003e \u003cp\u003eMalignant Pilomatricoma (Pilomatrical Carcinoma) 140\u003c\/p\u003e \u003cp\u003eTrichilemmal Carcinoma 141\u003c\/p\u003e \u003cp\u003eTrichoblastic Carcinoma 142\u003c\/p\u003e \u003cp\u003ePilosebaceous Mesenchyme 143\u003c\/p\u003e \u003cp\u003eBenign Neoplasm 143\u003c\/p\u003e \u003cp\u003eTrichodiscoma (Follicular Fibroma, Fibrofolliculoma, Perifollicular Fibroma) 143\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 PAGET’S DISEASE 145\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eMammary Paget’s Disease 146\u003c\/p\u003e \u003cp\u003eExtramammary Paget’s Disease 146\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 MELANOCYTES 149\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eNon‐Neoplastic Hyperpigmentations 150\u003c\/p\u003e \u003cp\u003eEphelides (Genuine Freckles) 150\u003c\/p\u003e \u003cp\u003ePUVA (Psoralen UVA) Lentigo 150\u003c\/p\u003e \u003cp\u003e“Nevus” Spilus (Speckled Lentiginous Nevus; Café‐Au‐Lait Spot) 151\u003c\/p\u003e \u003cp\u003e“Ink” Spot Lentigo (Reticulated Melanocytic Macule) 152\u003c\/p\u003e \u003cp\u003eSenile Freckles (Solar [Actinic] Lentigo) 153\u003c\/p\u003e \u003cp\u003eMucosal Lentiginous Spots (Lip, Buccal, and Genital Mucosa) 154\u003c\/p\u003e \u003cp\u003eNevi 155\u003c\/p\u003e \u003cp\u003eCommon Acquired Melanocytic Nevi 155\u003c\/p\u003e \u003cp\u003eMelanosis Neviformis (Pigmented Hairy Epidermal Nevus; Becker Nevus) 155\u003c\/p\u003e \u003cp\u003eJunctional Nevus 156\u003c\/p\u003e \u003cp\u003eCompound Nevus 157\u003c\/p\u003e \u003cp\u003eDermal Nevus 158\u003c\/p\u003e \u003cp\u003eVariant: Miescher’s Nevus (Dermal Nevus) 160\u003c\/p\u003e \u003cp\u003eVariant: Balloon Cell Nevus 161\u003c\/p\u003e \u003cp\u003eVariant: “Activated” Acral (Lentiginous) Melanocytic Nevus 161\u003c\/p\u003e \u003cp\u003eVariant: (Atypical) Genital Melanocytic Nevus 162\u003c\/p\u003e \u003cp\u003eVariant: Halo Nevus (Leukoderma Centrifugum Acquisitum; Sutton Nevus) 163\u003c\/p\u003e \u003cp\u003eVariant: Eczematoid Melanocytic (Meyerson’s) Nevus 165\u003c\/p\u003e \u003cp\u003eVariant: Osteo‐Nevus of Nanta 166\u003c\/p\u003e \u003cp\u003eVariant: Combined Epithelioid Spitzoid Nevus, “Wiesner Nevus” (BAP-1 Deficient Epithelioid Melanocytic Tumor) 167\u003c\/p\u003e \u003cp\u003eVariant: Recurrent (Persistent) Melanocytic Nevus (Pseudomelanoma) 167\u003c\/p\u003e \u003cp\u003eVariant: Nevus in Pregnancy 168\u003c\/p\u003e \u003cp\u003eVariant: Ancient Nevus 170\u003c\/p\u003e \u003cp\u003eBlue Nevi 171\u003c\/p\u003e \u003cp\u003eCommon Blue Nevus 171\u003c\/p\u003e \u003cp\u003eCommon Blue Nevus 172\u003c\/p\u003e \u003cp\u003eDermal Melanocytosis 177\u003c\/p\u003e \u003cp\u003eNevus Fuscoceruleus (Ota; Ito; Mongolian Spot) 177\u003c\/p\u003e \u003cp\u003eSpindle and\/or Epithelioid Cell Nevus 178\u003c\/p\u003e \u003cp\u003eCommon Nevus of Spitz 178\u003c\/p\u003e \u003cp\u003eVariants of Spindle and Epithelioid Cell Nevus 179\u003c\/p\u003e \u003cp\u003eVariant: Pigmented Spindle Cell Nevus (Reed) 182\u003c\/p\u003e \u003cp\u003eBenign Melanocytic Lesions with Peculiar Structural Features 183\u003c\/p\u003e \u003cp\u003eMelanocytic Nevus with Clonal Proliferation 183\u003c\/p\u003e \u003cp\u003eAtypical (Dysplastic) Melanocytic (Clark’s) Nevus (B‐K Mole Syndrome) 185\u003c\/p\u003e \u003cp\u003eCongenital Nevi, Small and Medium‐Sized (1.5–20 cm) 186\u003c\/p\u003e \u003cp\u003eMalignant Melanocytic Neoplasms 188\u003c\/p\u003e \u003cp\u003eLentigo Maligna Dubreuilh (Hutchinson’s Freckle) 188\u003c\/p\u003e \u003cp\u003eMalignant Melanoma 189\u003c\/p\u003e \u003cp\u003eVariant: Superficial Spreading Melanoma (SSM) 190\u003c\/p\u003e \u003cp\u003eVariant: Lentigo Maligna Melanoma (LMM) 192\u003c\/p\u003e \u003cp\u003eVariant: Nodular Melanoma (NM) 193\u003c\/p\u003e \u003cp\u003eVariant: Acral Lentiginous Melanoma (ALM) 194\u003c\/p\u003e \u003cp\u003eVariant: Melanoma in Large Congenital Melanocytic Nevus (LCMN) 196\u003c\/p\u003e \u003cp\u003eVariant: Cutaneous Metastasis of Melanoma 197\u003c\/p\u003e \u003cp\u003eSpecial Localisations of Malignant Melanoma 204\u003c\/p\u003e \u003cp\u003eTumor Thickness and Levels 205\u003c\/p\u003e \u003cp\u003eCommon Clinical Differential Diagnoses of Malignant Melanoma 205\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 CONNECTIVE TISSUE 207\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eNevi 208\u003c\/p\u003e \u003cp\u003eConnective Tissue Nevus (Shagreen Patch; Cobblestone Nevus; Nevus Collagenicus) 208\u003c\/p\u003e \u003cp\u003eFibrous Neoplasms 209\u003c\/p\u003e \u003cp\u003eSoft Fibroma (Skin Tag; Acrochordon) 209\u003c\/p\u003e \u003cp\u003ePerifollicular Fibroma (Fibrofolliculoma; Trichodiscoma) 210\u003c\/p\u003e \u003cp\u003eVariant: Sclerotic Fibroma (Plywood Fibroma; Storiform Collagenoma) 211\u003c\/p\u003e \u003cp\u003eVariant: Fibrous Papule of the Nose 212\u003c\/p\u003e \u003cp\u003eVariant: Pleomorphic Sclerosing Fibroma with Multinucleated Cells 212\u003c\/p\u003e \u003cp\u003eKeloid 213\u003c\/p\u003e \u003cp\u003eInfantile Digital Fibromatosis (Inclusion Body Fibromatosis; Recurring Digital Fibrous Tumor of Children; Reye’s Tumor) 214\u003c\/p\u003e \u003cp\u003eMalformations with Supernumerary Tissue Elements 216\u003c\/p\u003e \u003cp\u003eSupernumerary Digit (Rudimentary Digit; Rudimentary Polydactyly) 216\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis: Acral Acquired Fibrokeratoma 216\u003c\/p\u003e \u003cp\u003eAccessory Tragus (Preauricular Tag) 217\u003c\/p\u003e \u003cp\u003eAccessory Nipple (Ectopic Breast; Polythelia) 218\u003c\/p\u003e \u003cp\u003eFibrohistiocytic Neoplasms 218\u003c\/p\u003e \u003cp\u003eDermatofibroma (Benign Fibrous Histiocytoma; Fibroma Durum; Sclerosing Hemangioma) 218\u003c\/p\u003e \u003cp\u003eDermatofibrosarcoma Protuberans 227\u003c\/p\u003e \u003cp\u003eVariant: Pigmented Dermatofibrosarcoma Protuberans (Bednar’s Tumor) 230\u003c\/p\u003e \u003cp\u003eVariant: Giant Cell Fibroblastoma 231\u003c\/p\u003e \u003cp\u003ePleomorphic Dermal Sarcoma (PDS) 231\u003c\/p\u003e \u003cp\u003eMiscellaneous Tumors 234\u003c\/p\u003e \u003cp\u003eEpithelioid Sarcoma 234\u003c\/p\u003e \u003cp\u003eDermatomyofibroma 236\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 VESSELS 239\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eHamartomas, Nevi, and Malformations 240\u003c\/p\u003e \u003cp\u003ePhacomatosis Pigmentovascularis 240\u003c\/p\u003e \u003cp\u003eEccrine Angiomatous Hamartoma 241\u003c\/p\u003e \u003cp\u003eNevus Anemicus 242\u003c\/p\u003e \u003cp\u003eCapillary Malformations 242\u003c\/p\u003e \u003cp\u003eNevus Flammeus (Port-Wine Stain) 242\u003c\/p\u003e \u003cp\u003eNevus Araneus (Spider Angioma) 244\u003c\/p\u003e \u003cp\u003eCutis Marmorata Telangiectatica (van Lohuizen) (Nevus Vascularis Reticularis) 245\u003c\/p\u003e \u003cp\u003eCongenital Telangiectatic Erythema (Bloom’s Syndrome) 247\u003c\/p\u003e \u003cp\u003eVenous Malformations 248\u003c\/p\u003e \u003cp\u003eBlue Rubber Bleb Nevus Syndrome (Familial Venous Malformation) 248\u003c\/p\u003e \u003cp\u003eHereditary Hemorrhagic Telangiectasia (Osler–Weber–Rendu) 249\u003c\/p\u003e \u003cp\u003eAngioma Serpiginosum 250\u003c\/p\u003e \u003cp\u003eVenular Aneurysm (Venous Lake) 251\u003c\/p\u003e \u003cp\u003eCavernous Hemangioma (in Maffucci Syndrome) 252\u003c\/p\u003e \u003cp\u003eSinusoidal Hemangioma 253\u003c\/p\u003e \u003cp\u003eSpindle Cell Hemangioma (Formerly Spindle Cell Hemangioendothelioma) 254\u003c\/p\u003e \u003cp\u003eArteriovenous Malformations 256\u003c\/p\u003e \u003cp\u003eAcral Arteriovenous Hemangioma (Cirsoid Aneurysm) 256\u003c\/p\u003e \u003cp\u003eGlomuvenular Malformation (“Glomangioma”) 257\u003c\/p\u003e \u003cp\u003eLymphatic Malformations 259\u003c\/p\u003e \u003cp\u003eSuperficial Lymphatic Malformation (Superficial Lymphangioma) 259\u003c\/p\u003e \u003cp\u003eCystic Lymphatic Malformation (Cystic Hygroma) 260\u003c\/p\u003e \u003cp\u003eTargetoid Hemosiderotic (Hobnail) Hemangioma 261\u003c\/p\u003e \u003cp\u003eProgressive Lymphangioma (Benign Lymphangioendothelioma) 262\u003c\/p\u003e \u003cp\u003eLymphangiomatosis 263\u003c\/p\u003e \u003cp\u003eAngiokeratomas 264\u003c\/p\u003e \u003cp\u003eVerrucous Hemangioma (Venous Malformation) 265\u003c\/p\u003e \u003cp\u003eVariant: Solitary Angiokeratoma 268\u003c\/p\u003e \u003cp\u003eVariant: Angiokeratoma Circumscriptum Naeviformis 269\u003c\/p\u003e \u003cp\u003eVariant: Fordyce Angiokeratoma 269\u003c\/p\u003e \u003cp\u003eVariant: Angiokeratoma Acroasphycticum Digitorum (Mibelli) 269\u003c\/p\u003e \u003cp\u003eVariant: Multiple “Pinpoint” Angiokeratomas (Angiokeratoma Corporis Diffusum; Fabry’s Disease) 269\u003c\/p\u003e \u003cp\u003eVariant: Acral Pseudolymphomatous Angiokeratoma of Children (APACHE) 269\u003c\/p\u003e \u003cp\u003eHyperplasias 270\u003c\/p\u003e \u003cp\u003eGranuloma Pyogenicum (Lobular Capillary Hemangioma; Botryomykoma) 270\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis: Pyogenic Granuloma‐Like Granulation Tissue 272\u003c\/p\u003e \u003cp\u003eBacillary Angiomatosis 273\u003c\/p\u003e \u003cp\u003eVerruga Peruana 274\u003c\/p\u003e \u003cp\u003eIntravascular Papillary Endothelial Hyperplasia (Masson) 275\u003c\/p\u003e \u003cp\u003eAcroangiodermatitis Mali (Pseudo‑Kaposi’s Sarcoma) 276\u003c\/p\u003e \u003cp\u003eBenign Vascular Neoplasms 278\u003c\/p\u003e \u003cp\u003eEpithelioid Hemangioma (Angiolymphoid Hyperplasia with Eosinophilia, ALHE) 278\u003c\/p\u003e \u003cp\u003eEndothelial Differentiation 280\u003c\/p\u003e \u003cp\u003eInfantile Capillary and Congenital Hemangioma 280\u003c\/p\u003e \u003cp\u003eCherry Angioma (Senile Hemangioma) 281\u003c\/p\u003e \u003cp\u003eMicrovenular (Microcapillary) Hemangioma 282\u003c\/p\u003e \u003cp\u003eTufted Angioma 283\u003c\/p\u003e \u003cp\u003eKaposiform Hemangioendothelioma 285\u003c\/p\u003e \u003cp\u003eGlomeruloid Hemangioma in POEMS Syndrome 287\u003c\/p\u003e \u003cp\u003ePericytic Differentiation 288 Imitator: Solitary Fibrous Tumor of the Skin (SFT) 289\u003c\/p\u003e \u003cp\u003eMyopericytoma (Infantile Myofibromatosis; Perivascular Myoma (incl. Myofibroma)) 290\u003c\/p\u003e \u003cp\u003eGlomoid and Myoid Differentiation 292\u003c\/p\u003e \u003cp\u003eGlomus Tumor 292\u003c\/p\u003e \u003cp\u003eAngioleiomyoma (Angiomyoma; Vascular Leiomyoma) 294\u003c\/p\u003e \u003cp\u003eRecently Described Benign Vascular Tumors 296\u003c\/p\u003e \u003cp\u003eSymplastic Hemangioma 296\u003c\/p\u003e \u003cp\u003ePapillary Hemangioma 297\u003c\/p\u003e \u003cp\u003eVascular Neoplasms of Intermediate Malignant Potential 298\u003c\/p\u003e \u003cp\u003eKaposi’s Sarcoma (KS) 298\u003c\/p\u003e \u003cp\u003eRetiform Hemangioendothelioma 305\u003c\/p\u003e \u003cp\u003eComposite Hemangioendothelioma 306\u003c\/p\u003e \u003cp\u003ePapillary Intralymphatic Angioendothelioma (PILA) (Malignant Endovascular Papillary Angioendothelioma (Dabska Tumor); Endovascular Papillary Hemangioendothelioma) 306\u003c\/p\u003e \u003cp\u003eRadiation‐Induced Atypical Vascular Lesion (AVL) (Benign Lymphangiomatous Papule (BLAP)) 308\u003c\/p\u003e \u003cp\u003eVascular Neoplasms with High Malignant Potential 309\u003c\/p\u003e \u003cp\u003eCutaneous Angiosarcoma 309\u003c\/p\u003e \u003cp\u003eRadiation‐Induced (Postradiation) Angiosarcoma 312\u003c\/p\u003e \u003cp\u003eEpithelioid Hemangioendothelioma 312\u003c\/p\u003e \u003cp\u003eEpithelioid Angiosarcoma 315\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis: Acantholytic (Angiosarcoma‐Like) Squamous Cell Carcinoma 316\u003c\/p\u003e \u003cp\u003eGlomangiosarcoma (Malignant Glomus Tumor) 317\u003c\/p\u003e \u003cp\u003eOther Neoplasms with Significant Vascular Component 318\u003c\/p\u003e \u003cp\u003eMultinucleate Angiohistiocytoma 318\u003c\/p\u003e \u003cp\u003eAngiofibroma (Adenoma Sebaceum Associated with Pringle–Bourneville Disease) 319\u003c\/p\u003e \u003cp\u003eAngiolipoma 321\u003c\/p\u003e \u003cp\u003eAngiolipoleiomyoma (Angiomyolipoma) 322\u003c\/p\u003e \u003cp\u003eAngiomyxoma 322\u003c\/p\u003e \u003cp\u003eIntralymphatic Histiocytosis 324\u003c\/p\u003e \u003cp\u003eKimura’s Disease 325\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 FAT 327\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eNevus (Hamartoma) 328\u003c\/p\u003e \u003cp\u003eNevus Lipomatosus Superficialis Hoffmann Zurhelle 328\u003c\/p\u003e \u003cp\u003eNeoplasms of Fat Tissue 329\u003c\/p\u003e \u003cp\u003eBenign Neoplasms 329\u003c\/p\u003e \u003cp\u003eCommon Lipoma and Lipomatosis 329\u003c\/p\u003e \u003cp\u003eAngiolipoma (see Vessels, Chapter 6) 330\u003c\/p\u003e \u003cp\u003eAngiomyolipoma (see Vessels, Chapter 6) 330\u003c\/p\u003e \u003cp\u003eSpindle Cell Lipoma 330\u003c\/p\u003e \u003cp\u003ePleomorphic Lipoma (see Pleomorphic Liposarcoma) 332\u003c\/p\u003e \u003cp\u003eHibernoma 332\u003c\/p\u003e \u003cp\u003eMalignant Neoplasms 333\u003c\/p\u003e \u003cp\u003eCutaneous Liposarcoma 333\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 MUSCLE 337\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eBenign Neoplasms 338\u003c\/p\u003e \u003cp\u003ePiloleiomyoma (Pilar Leiomyoma) 338\u003c\/p\u003e \u003cp\u003eAngioleiomyoma (see Vessels, Chapter 6) 340\u003c\/p\u003e \u003cp\u003eRhabdomyoma, Adult Type 340\u003c\/p\u003e \u003cp\u003eMalignant Neoplasms 341\u003c\/p\u003e \u003cp\u003eRhabdomyosarcoma 341\u003c\/p\u003e \u003cp\u003eSuperficial Leiomyosarcoma 342\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 NERVES 345\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eBenign Neoplasms 346\u003c\/p\u003e \u003cp\u003eSchwannoma (Neurilemmoma) 349\u003c\/p\u003e \u003cp\u003eSolitary Neuroma (“Palisaded Encapsulated Neuroma”) 352\u003c\/p\u003e \u003cp\u003eVariant: Traumatic Neuroma 353\u003c\/p\u003e \u003cp\u003eGranular Cell Tumor (Abrikossoff) 354\u003c\/p\u003e \u003cp\u003eDermal Nerve Sheath Myxoma (Myxoid Neurothekeoma) 356\u003c\/p\u003e \u003cp\u003eVariant: Cellular Neurothekeoma 357\u003c\/p\u003e \u003cp\u003ePacinian Neurofibroma (Pacinoma) 358\u003c\/p\u003e \u003cp\u003eMalignant Neoplasms 358\u003c\/p\u003e \u003cp\u003eMalignant Peripheral Nerve Sheath Tumor (Malignant Schwannoma) 358\u003c\/p\u003e \u003cp\u003eMalignant Granular Cell Tumor 360\u003c\/p\u003e \u003cp\u003eNeuroendocrine Neoplasm 360\u003c\/p\u003e \u003cp\u003ePrimary Neuroendocrine (Merkel Cell, Trabecular) Carcinoma of the Skin 360\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 MAST CELLS 363\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eSolitary Cutaneous Mast Cell Proliferation 364\u003c\/p\u003e \u003cp\u003eCutaneous Mastocytoma 364\u003c\/p\u003e \u003cp\u003eDiffuse Cutaneous Mast Cell Proliferations 365\u003c\/p\u003e \u003cp\u003eUrticaria Pigmentosa (Juvenile Maculopapular Mastocytosis) 365\u003c\/p\u003e \u003cp\u003eTelangiectasia Macularis Eruptiva Perstans (Adults) 365\u003c\/p\u003e \u003cp\u003eSystemic Mast Cell Proliferation 367\u003c\/p\u003e \u003cp\u003eInvolvement of Skin and Bone Marrow 367\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 HISTIOCYTES 369\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eLangerhans Cell Histiocytoses (LCH) 370\u003c\/p\u003e \u003cp\u003ePrecursors of Langerhans Cell Histiocytoses 370\u003c\/p\u003e \u003cp\u003eCongenital Self‐healing Reticulohistiocytosis (Hashimoto–Pritzker) 370\u003c\/p\u003e \u003cp\u003eIndeterminate Cell Histiocytosis 371\u003c\/p\u003e \u003cp\u003eLangerhans Cell Histiocytoses (Histiocytosis X) 371\u003c\/p\u003e \u003cp\u003eCongenital Langerhans Cell Histiocytosis (Letterer–Siwe Disease) 372\u003c\/p\u003e \u003cp\u003eHand–Schüller–Christian Adult LHC Histiocytosis 374\u003c\/p\u003e \u003cp\u003eSolitary Langerhans Cell Tumor (Eosinophilic Granuloma) 375\u003c\/p\u003e \u003cp\u003eNon‐Langerhans Cell Histiocytoses 376\u003c\/p\u003e \u003cp\u003eProliferative 376\u003c\/p\u003e \u003cp\u003eProliferative Histiocytoma (Progressive Nodular Histiocytosis, PNH) 376\u003c\/p\u003e \u003cp\u003eBenign Cephalic Histiocytosis 377\u003c\/p\u003e \u003cp\u003eMulticentric Reticulohistiocytosis (Lipoid Dermatoarthritis) (Solitary Reticulohistiocytoma) 378\u003c\/p\u003e \u003cp\u003eSinus Histiocytosis With Massive Lymphadenopathy 379\u003c\/p\u003e \u003cp\u003eGranulomatous Storing 380\u003c\/p\u003e \u003cp\u003eJuvenile Xanthogranuloma (Nevoxanthoendothelioma; Xanthoma Multiplex; Juvenile Giant Cell Granuloma) 380\u003c\/p\u003e \u003cp\u003eXanthelasma Palpebrarum 383\u003c\/p\u003e \u003cp\u003eVerruciform Xanthoma 384\u003c\/p\u003e \u003cp\u003eNecrobiotic Xanthogranuloma (with Paraproteinemia) 385\u003c\/p\u003e \u003cp\u003eHereditary Progressive Mucinous Histiocytosis 386\u003c\/p\u003e \u003cp\u003eHemophagocytic 387\u003c\/p\u003e \u003cp\u003eFamilial Hemophagocytic Lymphohistiocytosis 387\u003c\/p\u003e \u003cp\u003eHistiocytic Cytophagic Panniculitis 388\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 HEMATOPOIETIC DISORDERS 389\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eLymphoid Skin Infiltrates 389\u003c\/p\u003e \u003cp\u003eCytomorphology, Major Cell Types 390\u003c\/p\u003e \u003cp\u003eT‐Cells 390\u003c\/p\u003e \u003cp\u003eB‐Cells 391\u003c\/p\u003e \u003cp\u003ePattern of Small Cell Lymphocytic Infiltrates 392\u003c\/p\u003e \u003cp\u003eT‐Cell Pattern 392\u003c\/p\u003e \u003cp\u003eB‐Cell Pattern 392\u003c\/p\u003e \u003cp\u003ePseudolymphoma (PL) 393\u003c\/p\u003e \u003cp\u003eNodular B‐Cell PL 393\u003c\/p\u003e \u003cp\u003eLymphadenosis Cutis Benigna (Lymphocytoma Cutis) 393\u003c\/p\u003e \u003cp\u003eDifferentiation between B‑Pseudolymphoma (PL) and Cutaneous B‐Cell Lymphoma (CBCL) 395\u003c\/p\u003e \u003cp\u003eNodular T‐Cell PL 396\u003c\/p\u003e \u003cp\u003eCD30+ Pseudolymphoma in Scabies 396\u003c\/p\u003e \u003cp\u003ePapular (Secondary) Syphilis 398\u003c\/p\u003e \u003cp\u003ePseudo‐Mycosis Fungoides (Mycosis Fungoides Simulators) 399\u003c\/p\u003e \u003cp\u003eLymphomatoid Contact Dermatitis 399\u003c\/p\u003e \u003cp\u003eLichen Planus 399\u003c\/p\u003e \u003cp\u003eDrug Reactions 400\u003c\/p\u003e \u003cp\u003eEarly Vitiligo 400\u003c\/p\u003e \u003cp\u003eLichen Sclerosus et Atrophicus 400\u003c\/p\u003e \u003cp\u003ePityriasis Lichenoides Chronica 401\u003c\/p\u003e \u003cp\u003eGraft Versus Host Reaction (Acute) 401\u003c\/p\u003e \u003cp\u003ePityriasis Lichenoides et Varioliformis Acuta (PLEVA) 402\u003c\/p\u003e \u003cp\u003ePigmented Purpuric Dermatitis (Lichen Aureus) 403\u003c\/p\u003e \u003cp\u003eLymphocytic Infiltration Jessner–Kanof 404\u003c\/p\u003e \u003cp\u003eCutaneous Mature T‐Cell Lymphoid Neoplasms (CTCL) 405\u003c\/p\u003e \u003cp\u003eMycosis Fungoides, Classic Alibert–Bazin Type 405\u003c\/p\u003e \u003cp\u003eMycosis Fungoides Patch Stage I 405\u003c\/p\u003e \u003cp\u003eMycosis Fungoides Plaque Stage II (CD4+; CD8−) 407\u003c\/p\u003e \u003cp\u003eVariant: CD8+ Mycosis Fungoides 409\u003c\/p\u003e \u003cp\u003eMycosis Fungoides Tumor Stage III 409\u003c\/p\u003e \u003cp\u003eLarge Cell Transformation 410\u003c\/p\u003e \u003cp\u003eSimulators and Variants of Mycosis Fungoides: “Parapsoriasis” 411\u003c\/p\u003e \u003cp\u003eSimulator: Small Plaque Parapsoriasis (SPP) (Brocq’s Disease, Digitate Dermatosis) 411\u003c\/p\u003e \u003cp\u003eLarge Plaque Parapsoriasis (LPP) 412\u003c\/p\u003e \u003cp\u003ePigmented Purpuric Mycosis Fungoides 412\u003c\/p\u003e \u003cp\u003eErythrodermic Mycosis Fungoides 412\u003c\/p\u003e \u003cp\u003eFolliculotropic (Pilotropic) Mycosis Fungoides 413\u003c\/p\u003e \u003cp\u003eSyringotropic Mycosis Fungoides (Syringolymphoid Hyperplasia with Alopecia) 414\u003c\/p\u003e \u003cp\u003eGranulomatous Mycosis Fungoides 415\u003c\/p\u003e \u003cp\u003eGranulomatous Slack Skin 415\u003c\/p\u003e \u003cp\u003ePagetoid Reticulosis (PR), Unilesional (Woringer–Kolopp) 417\u003c\/p\u003e \u003cp\u003eSézary Syndrome (SS) 418\u003c\/p\u003e \u003cp\u003eVariant: Sézary Syndrome, Large Cell Transformation 420\u003c\/p\u003e \u003cp\u003eCD30‐Positive Lymphoproliferative Disorders (LPD) of the Skin 423\u003c\/p\u003e \u003cp\u003eAnaplastic Large Cell Lymphoma (ALCL) 424\u003c\/p\u003e \u003cp\u003eNeutrophil‐Rich (Pyogenic) Anaplastic Large Cell Lymphoma 426\u003c\/p\u003e \u003cp\u003eLymphomatoid Papulosis 427\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis: Hodgkin’s Lymphoma, Lymphocyte Predominance 429\u003c\/p\u003e \u003cp\u003eSubcutaneous Panniculitis‐Like Lymphoma 431\u003c\/p\u003e \u003cp\u003eSubcutaneous (Panniculitis-Like; Alpha\/Beta) T‐Cell Lymphoma 431\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis: Subcutaneous (Panniculitis‐Like) Gamma\/Delta lymphoma 432\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis: Lupus Panniculitis (Lupus Profundus) 433\u003c\/p\u003e \u003cp\u003ePrimary Cutaneous Peripheral Lymphoma (PTL), Unspecified (NOS) 434\u003c\/p\u003e \u003cp\u003ePrimary Cutaneous CD4‐positive (Acral) Small\/Medium‐Sized T‐Cell Lymphoproliferative Disorder 435\u003c\/p\u003e \u003cp\u003eCutaneous Aggressive Epidermotropic CD8‐positive T‐Cell Lymphoma (Berti) 436\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis: Febrile Ulceronecrotic PLEVA (Mucha–Habermann Disease) 437\u003c\/p\u003e \u003cp\u003eExtranodal NK\/T‐Cell Lymphoma, Nasal Type (Subcutaneous) 439\u003c\/p\u003e \u003cp\u003eHydroa Vacciniforme‐Like Lymphoma 440\u003c\/p\u003e \u003cp\u003eAngioimmunoblastic T‐Cell Lymphoma 441\u003c\/p\u003e \u003cp\u003eCutaneous Mature B‐Cell Lymphoid Neoplasms (CBCL) 443\u003c\/p\u003e \u003cp\u003eCutaneous Marginal Zone B‐Cell Lymphoma (MZL; MALT Type) 444\u003c\/p\u003e \u003cp\u003eVariant: Immunocytoma 447\u003c\/p\u003e \u003cp\u003eDifferential Diagnoses: Multiple Myeloma\/Plasmacytoma 448\u003c\/p\u003e \u003cp\u003ePrimary Cutaneous Follicle Center Lymphoma (FCL) 449\u003c\/p\u003e \u003cp\u003eDiffuse Large B‐Cell Lymphoma (DLBCL) 451\u003c\/p\u003e \u003cp\u003eVariant: Cutaneous Diffuse Large B‐Cell Lymphoma (Leg Type) 451\u003c\/p\u003e \u003cp\u003eVariant: T‐Cell‐Rich B‐Cell Lymphoma (DLBCL) 454\u003c\/p\u003e \u003cp\u003eCutaneous Spindle B‐Cell Lymphoma 455\u003c\/p\u003e \u003cp\u003eExtracutaneous B‐Cell Lymphoma (BCL) with Frequent Skin Involvement 457\u003c\/p\u003e \u003cp\u003eMantle Cell Lymphoma 457\u003c\/p\u003e \u003cp\u003eBurkitt’s Lymphoma (BL) 458\u003c\/p\u003e \u003cp\u003eLymphomatoid Granulomatosis (Liebow) (LYG) 460\u003c\/p\u003e \u003cp\u003eIntravascular Lymphomas 461\u003c\/p\u003e \u003cp\u003eIntravascular Large B‐Cell Lymphoma (IV‐LBCL) (Systemic Angioendotheliomatosis) 461\u003c\/p\u003e \u003cp\u003eIntravascular T Cell Lymphoma 462\u003c\/p\u003e \u003cp\u003eSecondary Skin Involvement in Leukemias\/Lymphomas 463\u003c\/p\u003e \u003cp\u003eChronic Lymphocytic Leukemia (CLL) 463\u003c\/p\u003e \u003cp\u003eMyeloid and Monocytic Leukemias 464\u003c\/p\u003e \u003cp\u003eT‐Zone Lymphoma 466\u003c\/p\u003e \u003cp\u003eAdult T‐Cell Leukemia\/ Lymphoma (ATLL) 467\u003c\/p\u003e \u003cp\u003eImmature Hematopoietic Malignancies 468\u003c\/p\u003e \u003cp\u003eBlastic Plasmacytoid Dendritic Cell Neoplasm 468\u003c\/p\u003e \u003cp\u003ePrecursor Lymphoblastic Leukemia\/Lymphoma 470\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 CUTANEOUS CYSTS 471\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eCysts with Epithelial Lining 472\u003c\/p\u003e \u003cp\u003eStratified Squamous Epithelium 472\u003c\/p\u003e \u003cp\u003eEpidermal (Infundibular) Cysts 472\u003c\/p\u003e \u003cp\u003eVariant: Epidermal Proliferating Cyst 473\u003c\/p\u003e \u003cp\u003eVariant: Epidermal Cyst with Pigment and Vellus Hairs 473\u003c\/p\u003e \u003cp\u003eVellus Hair Cyst 474\u003c\/p\u003e \u003cp\u003eTrichilemmal (Isthmus‐Catagen) Cyst 475\u003c\/p\u003e \u003cp\u003eMilia 476\u003c\/p\u003e \u003cp\u003eFollicular Hybrid Cyst 477\u003c\/p\u003e \u003cp\u003eHidrocystoma (Cystadenoma) 478\u003c\/p\u003e \u003cp\u003eSteatocystoma, Multiplex and Simplex 481\u003c\/p\u003e \u003cp\u003eDermoid Cyst 482\u003c\/p\u003e \u003cp\u003ePilonidal Sinus (Pilonidal Cyst) 484\u003c\/p\u003e \u003cp\u003eNon‐Stratified Squamous Epithelium 485\u003c\/p\u003e \u003cp\u003eCutaneous Ciliated Cyst of the Lower Limb 485\u003c\/p\u003e \u003cp\u003eMedian Raphe Cyst 486\u003c\/p\u003e \u003cp\u003eCysts without Epithelial Lining (Pseudocysts) 487\u003c\/p\u003e \u003cp\u003eOral Mucous Cyst and Superficial Mucocele of the Lip 487\u003c\/p\u003e \u003cp\u003eDigital Myxoid Cyst 488\u003c\/p\u003e \u003cp\u003eSynovial Cyst (Ganglion) 490\u003c\/p\u003e \u003cp\u003eIndex 491\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49407040356695,"sku":"9781119371540","price":117.75,"currency_code":"GBP","in_stock":false}],"url":"https:\/\/bookcurl.com\/products\/atlas-of-dermatopathology-9781119371540","provider":"Book Curl","version":"1.0","type":"link"}